Cue Biopharma Statistics
NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
22.51-0.63 (-2.72%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cue Biopharma by the numbers
Cue Biopharma has a market capitalization of $163.5 million based on 7.26M shares outstanding. With trailing EPS of $-29.59, Cue Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.7% below its 50-day average and 11.3% above its 200-day average.
Average daily trading volume is 269.82K shares, or about $6.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CUE valuation vs. peer median
| Metric | CUE | Peer median | Difference |
|---|---|---|---|
| Market cap | $163.52M | $164.30M | -0% |
| Avg. volume | 269.82K | 327.37K | -18% |
Peer median across 8 companies: NKTX, EMIS, MSLE, PEPG, DERM, NBP, VRXA, ORGO.
Valuation
- Market cap
- $163.52M
- EPS (TTM)
- $-29.59
- Shares outstanding
- 7.26M
Price and trading
- Previous close
- 23.14
- Open
- 22.92
- Day range
- 22.27 – 23.09
- 52-week range
- 4.98 – 45.50
- 52-week change
- -0.22%
- Beta
- —
- Volume
- 132.22K
- Average volume
- 269.82K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 163.52M
- Forward Pe
- -46.90
- Eps
- -29.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 45.50
- Week52 Low
- 4.98
- Avg Volume
- 269.82K
- Shares Outstanding
- 7.26M
- Ma50
- 28.39
- Ma200
- 20.22
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -50.53%
- Pct From52w Low
- 352.01%